This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Scientists engineer CRISPR enzymes that evade the immune system By Allessandra DiCorato January 9, 2025 Breadcrumb Home Scientists engineer CRISPR enzymes that evade the immune system The new genome-editing tools could lead to safer, more efficient gene therapies. Lisa Yang Center for Autism Research at MIT, and the K.
A new paper showcases the power of scalable protein engineering combined with machine learning to boost progress in the field of gene and cell therapy. Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement.
Here we report the crystal structure of human USP30 in complex with a specific inhibitor, enabled by chimeric protein engineering. Collectively, our work establishes a generalizable chimeric protein-engineering strategy to aid deubiquitinase crystallization and enables structure-based drug design with relevance to neurodegeneration.
Illinois engineers fused ultrafast imaging with smart algorithms to peek at living brain chemistry, turning routine MRIs into metabolic microscopes. The system distinguishes healthy regions, grades tumors, and forecasts MS flare-ups long before structural MRI can. Precision-medicine neurology just moved closer to reality.
Exploiting the unique topologies and functionalities of the different binding sites enabled the engineering of selectivity for this initial molecular glue matter for the pS214 binding site, over a second 14-3-3 binding site in Tau (pS324).
The technology works by attaching a radioisotope to a targeting compound via a specially engineered “linker” molecule. Dive Insight: Radiopharmaceuticals offer a better way to target tumor-killing radiation more precisely to cancerous cells and, accordingly, they’ve drawn rising interest from drugmakers.
One company leading the charge in this revolution is Alltrna , whose pioneering work in engineered transfer RNA (tRNA) therapeutics is offering new hope for patients with rare genetic diseases. we are first focused on engineering tRNAs to restore protein production in diseases caused by premature termination codons.
With coral reefs in crisis due to climate change, scientists have engineered a bio-ink that could help promote coral larvae settlement and restore these underwater ecosystems before it's too late.
With a background in neurobiology, immuno-oncology and bispecific engineering, JJ now leads the development of antibody candidates designed to go further. The main challenge was engineering a molecule that could precisely engage p95HER2 and simultaneously trigger immune activation through CD137. They are starting points.
µM in engineered BaF3-EGFRL858R/T790M/C797S and NCI-H1975 cells, respectively, overcoming EAI045's limitation of lack in cellular potency as a single agent. Compound 4 showed potent inhibition of EGFR-driven cell proliferation with IC50 values of 0.789 µM and 1.22
Leveraging the extensive breadth of available data to identify entities and relationships across data sources, clinical research experts, therapeutic specialists, machine learning (ML) engineers and others can collectively evaluate areas of interest that may create new opportunities for the asset and a broader clinical strategy.
In just two years, CTMC has advanced eight therapies into clinical trials, harnessing genetic engineering to enhance T-cell effectiveness in the fight against cancer. Bock highlighted ongoing efforts to enhance the effectiveness of cell therapies through advanced genetic engineering to make T cells more effective in the fight against cancer.
Zhang, the James and Patricia Poitras Professor of Neuroscience at MIT and a professor of brain and cognitive sciences and biological engineering, was among nine individual recipients of the award.
When paired with AI, it can transform noisy biological complexity into structured, predictive frameworks – shifting the role of machine learning from a descriptive tool to a discovery engine. Francisco’s experience includes almost 19 years at Illumina, most recently as Vice President of Software Engineering and Embedded Systems.
The strikingly different shapes of acyl cavities in TEs of known structure, including those reported here for juvenimicin, tylosin and fluvirucin biosynthesis, provide insights to facilitate TE engineering and optimization.
2 A raft of emerging therapeutic modalities sits at the centre of this boom, spanning advanced biologics, engineered platforms and next-generation small molecules. Molecular engineering approaches Most CNS disorders involve abnormal gene expression, and molecular engineering is one of the most powerful tools to address this issue.
Tseo is joined on the paper by co-lead author Xinyi Zhang, a graduate student in the Department of Electrical Engineering and Computer Science (EECS) and the Eric and Wendy Schmidt Center at the Broad Institute; Yunhao Bai of the Broad Institute; and senior authors Fei Chen , an assistant professor at Harvard and a core institute member of the Broad (..)
Recently, a team of scientists and engineers has discovered a similar phenomenon on a microscopic scale, where tiny magnetic particles driven by rotating fields spontaneously move along the edges of clusters driven by invisible 'edge currents' that follow the rules of an unexpected branch of physics.
Scientists have used DNA's self-assembling properties to engineer intricate moiré superlattices at the nanometer scale—structures that twist and layer like never before. With clever molecular “blueprints,” they’ve created customizable lattices featuring patterns such as honeycombs and squares, all with remarkable precision.
Previously, Aaron was an algorithm engineer and manager of the hand tracking team at Leap Motion. Aaron Smith, Founder & Machine Learning Scientist at Unlearn Aaron Smith is a mathematician with research interests at the interface of computer vision, machine learning, physics, and geometry. Aaron received his Ph.D.
Abhishaike Mahajan is a senior ML engineer at Dyno Therapeutics, a biotech startup working to create better adeno-associated viral vectors using AI. He also writes on a blog focused on the intersection of biology and AI at owlposting.com.
“This study demonstrates the power of OPS to probe the dependency of dangerous viruses like Ebola on host factors at all stages of the viral life cycle and explore new routes to improve human health,” said co-senior author Paul Blainey , a Broad core faculty member and professor in the Department of Biological Engineering at MIT.
DARPins – designed ankyrin repeat proteins – are small, engineered protein scaffolds with high specificity and affinity, developed as an alternative to traditional antibodies. “I joined Molecular Partners four years ago as the Head of Preclinical Pharmacology Platforms,” she says. ” From there, things moved fast.
Most are concentrating on the delivery van and not necessarily on the package,” he adds, highlighting the industry’s tendency to focus on antibody engineering while underinvesting in payload innovation. “It’s almost both worlds coming together”. And we think the package is probably equally, if not more, important.”
Understanding Google Patents Google Patents is a search engine that allows users to search the full text of patent documents from around the world. While Google Patents is a widely used tool for searching patent information, it may not be the most effective solution for identifying drug patents.
Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. Schizophrenia risk from complex variation of complement component 4. 2016;530(7589):177-83. Workman MJ, Mahe MM, Trisno S, Poling HM, Watson CL, Sundaram N, et al. 2017;23(1):49-59. Assembling human brain organoids.
Engineered by Chugai Pharmaceutical Co., However, NXT007 takes the science a step further with refined molecular engineering aimed at achieving enhanced efficacy, longer dosing intervals, and a more predictable bleeding protection profile.
Microgravity crystallization, in combination with modern innovations in antibody engineering (e.g., Convenience is an increasingly common competitive lever in the biopharma industry, particularly for crowded targets. half-life extension) and formulation / delivery (e.g.,
Zylberberg shares a notable success story involving a CAR-T therapy developer – a type of cell therapy that uses genetically engineered T-cells to fight cancer. Real-world impact The impact of Kosten Digitals AI tools is already being felt in the CGT space.
Its templating engine, Twig, is simple and easy for beginners to use. SEO Extension Purpose: Improve your site’s visibility in search engines. Gives you control over how your content appears in search engine results and on social media. It’s simple to manage pages, media, blog entries, and plugins.
Salanersen was engineered as an advanced ASO therapeutic, building on Biogen’s experience with SPINRAZA. While the last decade has seen major breakthroughs in SMA treatment—including gene therapies like ZOLGENSMA® and ASOs like SPINRAZA—there remain substantial unmet medical needs.
The lack of collaboration between biologists, chemists, engineers and data scientists represents a significant barrier. He is a senior data scientist and holds a master’s degree from Roma Tre University in computer engineering, where he also held the role of research fellow.
Its applications include studying disease pathology to develop targeted therapeutics, visualising enzymes that can decompose plastics, and engineering solutions to antibiotic resistance, among many others. Further, trade secrets offer no protection against independent discovery or reverse engineering by competitors.
A Next-Generation Antibody-Drug Conjugate Targeting B7-H3 Ifinatamab deruxtecan is a potential first-in-class antibody-drug conjugate (ADC) specifically engineered to target B7-H3 , a surface protein overexpressed in many solid tumors, including prostate cancer.
The idea of genetically instructing T cells to specifically eliminate cancer cells was born in the 1980s, but it would take 20 years to bring it to patients, said Sadelain, who left MSKCC last year to become the Herbert and Florence Irving Professor of Medicine and director of the Columbia Initiative in Cell Engineering and Therapy.
ABBV-514 was engineered to selectively deplete CCR8+ Tregs, a subset with high tumour infiltration and suppressive capacity, without broadly compromising immune function. “Unleashing anti-tumour immunity by depleting Tregs is a promising therapeutic approach.”
HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the official launch of WuXiHigh™ 2.0 , a next-generation, high-throughput formulation development platform specifically engineered for high-concentration biologics. WuXi Biologics Launches WuXiHigh™ 2.0
Building on previous work by the vector-engineering lab of Ben Deverman at the Broad, the team developed a pair of adeno-associated viruses (AAVs) to package and deliver the base-editing machinery to brain cells. But the researchers needed to deliver the base editors to the brain.
Doctors took donor T cells and performed three precise base edits on them, engineering them to attack leukemia cells while leaving healthy cells alone. Indeed, in 2022 Alyssa Tapley became the first human to receive a base-edited therapeutic, treating her life-threatening T-cell leukemia that had not responded to other treatments.
Broads software engineering team and the large computational and biological scientists who are part of the Broad research community will be active contributors to the platform, with a continued commitment to open science and sharing reproducible techniques and insights.
Nick Ren is an engineer with a lot of experience working alongside geneticists. The query shown is from an initial chat without any prior prompt engineering or setup required." " Was there anything unexpected or particularly difficult? The hardest part is deciding which query patterns to expose as tools.
At the time, in India, we typically had two major career choices, engineering or medicine. With artificial intelligence, the pace of change is exciting for STEM, whether in medicine, engineering, space, or technology. I opted for medicine due to my love for biological sciences.
Beyond the clear clinical benefits demonstrated thus far, zimislecel represents a broader shift in the therapeutic landscape — one that leverages regenerative medicine, cellular engineering, and stem cell science to solve previously intractable medical challenges.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content